Patient intake software firm Phreesia's Q3 revenue slightly beats estimates

Overview

• Phreesia fiscal Q3 revenue slightly beats analyst expectations, growing 13% yr/yr

• Net income for fiscal Q3 was $4.3 mln, compared to a loss last year

• Company completed $160 mln acquisition of AccessOne, expected to boost future revenue

Outlook

• Phreesia updates fiscal 2026 revenue outlook to $479 mln-$481 mln

• Company raises fiscal 2026 adjusted EBITDA outlook to $99 mln-$101 mln

• Phreesia introduces fiscal 2027 revenue outlook of $545 mln-$559 mln

Result Drivers

• REVENUE PER CLIENT - Total revenue per healthcare services client increased by 6% year-over-year, contributing to overall revenue growth

• CLIENT BASE EXPANSION - Average number of healthcare services clients grew by 7% year-over-year, supporting revenue increase

• ACCESSONE ACQUISITION - Acquisition of AccessOne expected to enhance revenue and client offerings

Key Details

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 17 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the software peer group is "buy"

• Wall Street's median 12-month price target for Phreesia Inc is $34.00, about 67.6% above its December 5 closing price of $20.29

• The stock recently traded at 87 times the next 12-month earnings vs. a P/E of 379 three months ago

Press Release: ID:nBw29NxcYa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)